Browsing by Author
Erturk, Ismail
Showing results 1 to 4 of 4
| Issue Date | Title | Author(s) |
| 2023 | External Validation of a Novel Risk Model in Patients With Favorable Risk Renal Cell Carcinoma Defined by International Metastatic Renal Cell Carcinoma Database Consortium (imdc): Results From the Turkish Oncology Group Kidney Cancer Consortium (tkcc) Database | Yekeduz, Emre; Karakaya, Serdar; Erturk, Ismail; Tural, Deniz; Ucar, Gokhan; Oztas, Nihan Senturk; Arikan, Rukiye; Arslan, Çağatay |
| 2021 | Nivolumab in Metastatic Renal Cell Carcinoma: Results From the Turkish Oncology Group Kidney Cancer Consortium Database | Yekeduz, Emre; Erturk, Ismail; Tural, Deniz; Karadurmus, Nuri; Karakaya, Serdar; Hizal, Mutlu; Arikan, Rukiye |
| 2022 | The Relationship Between Pan-Immune Value and Survival Outcomes in Patients With Metastatic Renal Cell Carcinoma Treated With Nivolumab in the Second Line and Beyond: a Turkish Oncology Group Kidney Cancer Consortium (tkcc) Study | Yekeduz, Emre; Tural, Deniz; Erturk, Ismail; Karakaya, Serdar; Erol, Cihan; Ercelep, Ozlem; Arslan, Cagatay |
| 2022 | The Relationship Between Systemic Immune Inflammation Index and Survival in Patients With Metastatic Renal Cell Carcinomatreated Withtyrosine Kinase Inhibitors | Yucel, Kadriye Bir; Yekeduz, Emre; Karakaya, Serdar; Tural, Deniz; Erturk, Ismail; Erol, Cihan; Ercelep, Ozlem |
